Item 5. Market for Registrant’s Common Equity
Item 5.
Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
Market
Information
Our
Units issued in the Initial Public Offering began trading on the NYSE under the symbol “CPTK.U” on February 11, 2021.
Beginning on March 30, 2021, holders of our Units could elect to separately trade the shares of Class A ordinary shares and
public warrants contained in the Units or continue to trade the Units without separating them. On such date, the shares of Class A
ordinary shares and public warrants began trading on the NYSE under the symbols “CPTK” and “CPTK.WS,” respectively.
Each whole public warrant entitles the holder to purchase one share of Class A ordinary shares at a price of $11.50 per half share,
subject to adjustment as described in our final prospectus dated February 8, 2021 related to the Initial Public Offering which was
filed with the SEC. Warrants may only be exercised for a whole number of shares of Class A ordinary shares and will become exercisable
30 days after the completion of our initial business combination. Our warrants expire five years after the completion of our
initial business combination or earlier upon redemption or liquidation as described elsewhere in this Annual Report on Form 10-K.
On November 18, 2022, our public warrants were delisted and the NYSE determined that the public warrants should be suspended from
trading because the NYSE determined the public warrants were no longer suitable for listing based on “abnormally low” price
levels, pursuant to Section 802.01D of the NYSE Listed Company Manual. On the same day, the Company was notified and a press release
regarding the proposed delisting was issued and posted on the NYSE’s website. Trading in the public warrants was immediately suspended
on November 18, 2022. On December 7, 2022, the NYSE filed Form 25, pursuant to Rule 12d2-2(b), notifying the SEC of its intention
to remove the entire class of public warrants from listing and registration on the NYSE on December 19, 2022. Subsequent to the
delisting, our public warrants have traded on over-the-counter markets under the symbol “CPTKW.” Over-the-counter market
quotations reflect inter-dealer prices, without retail mark-up, mark-down or commission and may not necessarily represent actual transactions.
On
February 12, 2024, the NYSE determined that the Company was not in compliance with Section 802.01B and 102.06e of the NYSE Listed Company
Manual (the “LCM”) because the Company failed to consummate a Business Combination within the shorter of (i) the time period
specified by its constitutive documents or by contract or (ii) three years. As such, the NYSE had determined to commence proceedings
to delist from the NYSE the Company’s Class A ordinary shares and Units.
Trading
of the Company’s securities was suspended on February 12, 2024. The NYSE applied to the SEC to delist the Company’s securities
upon completion of all applicable procedures. The Company did not appeal the staff’s determination and, accordingly, the Company’s
securities were delisted from the NYSE.
Holders
As
of August 28, 2025, there was one holder of record of our Units, one holder of record of our Class A ordinary shares, 15 holders
of record of our Class B ordinary shares, and 10 holders of record of our warrants.
Dividends
We
have not paid any cash dividends on our ordinary shares to date and do not intend to pay cash dividends prior to the completion of our
initial business combination. The payment of cash dividends in the future will be dependent upon our revenues and earnings, if any, capital
requirements and general financial condition subsequent to completion of our initial business combination. The payment of any cash dividends
subsequent to our initial business combination will be within the discretion of our board of directors at such time. Further, if we incur
any indebtedness in connection with our business combination, our ability to declare dividends may be limited by restrictive covenants
we may agree to in connection therewith.
Securities
Authorized for Issuance Under Equity Compensation Plans
None
Performance
Graph
Not
applicable
69
Recent
Sales of Unregistered Securities; Use of Proceeds from Registered Offerings
Unregistered
Sales
On
January 17, 2023, CIIG entered into the Assignment Agreement whereby Crown PropTech Sponsor sold, transferred and assigned 5,662,000
Founder Shares of the Company and 250,667 Private Placement Warrants to purchase Class A ordinary shares of the Company to CIIG
for an aggregate purchase price of $21,717.21.Our Class B common stock will automatically convert into shares of Class A common
stock, on a one-for-one basis, upon the completion of a business combination.
The
sale of the Founder Shares and the Private Placement Warrants was made pursuant to the exemption from registration contained in Section 4(a)(2) of
the Securities Act.
Use
of Proceeds
Of
the $283,520,000 in proceeds, we received from our Initial Public Offering and the sale of the Private Placement Warrants, a total of
$276,000,000, including $9,660,000 payable to the underwriter for deferred underwriting commissions, was placed in the trust account.
However, in December 2022, we received a waiver letter from the underwriters electing to waive their entitlement to any deferred underwriting
commissions. The amount of funds available for a business combination is approximately $5,711,347.15 as of August 28, 2025, after payment
of an aggregate redemption amount of approximately $250,056.66 as a result of the approval on May 9, 2025 of the Extension Proposal.
There
has been no change in the planned use of proceeds from such use as described in the Company’s final prospectus (File No. 333-
252307), dated February 8, 2021, and filed with the SEC pursuant to Rule 424 under the Securities Act on February 10,
2021.
Purchases
of Equity Securities by the Issuer and Affiliated Purchasers
None.
Item 6.
[Reserved]
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.